History
# Registration date Revision Id
2 2024-03-21, 1403/01/02 297883
1 2021-12-03, 1400/09/12 207768
Changes made to previous revision
  • Help:

    Red color represents old content. It may be empty showing addition in the new version.
    Green color represents new content. It may be empty showing deletion in the new version.

    Inline Side by side
    Added new contents, deleted old contents, contents that are not changed.
    New table contents New table contents
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    Added new contents, contents that are not changed.
    Deleted old contents, contents that are not changed.
    Old table contents Old table contents
    Unchanged contents Unchanged contents
    New table contents New table contents
    Unchanged contents Unchanged contents
  • Protocol summary

    The effect of dry needling on pain and central sensitization (including the overall score of the Central sensitization Inventory (CSI), EEG activity as an indicator of brain functional changes, conditional pain modulation as a measure of endogenous central pain inhibitory system activity, cortisol biomarker through saliva as a measure of APH axis dysfunction) in women with chronic pelvic pain (CPP).
    The effect of dry needling on pain and central sensitization (including the Central Sensitization Inventory, electroencephalography, conditional pain modulation, salivary cortisol concentration, and psychosocial variables (7-item general anxiety disorder scale, pain catastrophizing scale, and SF-36 questionnaire) in women with chronic pelvic pain.
    بررسی تاثیر سوزن خشک بر درد و پارامترهای حساسیت مرکزی (شامل نمره کلی پرسشنامه حساسیت مرکزی (CSI)، فعالیت EEG به عنوان شاخصی از تغییرات عملکردی مغز ، تعدیل درد شرطی به عنوان معیاری از فعالیت سیستم مهارکننده درد مرکزی درون زا ، و بیومارکر کورتیزول بزاق به عنوان معیاری از اختلال عملکرد محور APH) در زنان مبتلا به درد مزمن لگن.
    بررسی اثر سوزن خشک بر درد و حساسیت مرکزی (شامل پرسشنامه حساسیت مرکزی (CSI)، الکتروانسفالوگرافی (EEG) به عنوان شاخص تغییرات عملکردی مغز، مدولاسیون شرطی درد به عنوان معیار فعالیت سیستم مهاری درد مرکزی درون زا، غلظت کورتیزول بزاقی به عنوان اندازه گیری اختلال عملکرد محور APH)، و متغیرهای روانی-اجتماعی (مقیاس 7 ماده ای اختلال اضطراب عمومی (GAD-7)، مقیاس فاجعه ساز درد (PCS) و پرسشنامه SF-36) در زنان مبتلا به درد مزمن لگن (CPP).
    Single-blind randomized, parallel-group controlled clinical trial, phase 3 on 36 patients. Participants will be divided into 3 groups of dry needle treatment, placebo dry needle group, and untreated control group using software and block randomization method.
    Single-blind randomized, parallel-group controlled clinical trial, on 36 patients. Randomization will be performed using a computerized Internet-based central randomization service (www.sealedenvelope.com). Assignments and allocation concealment will be sealed in sequentially numbered opaque envelopes by a person who had no direct role in the study.
    -کارآزمایی بالینی تصادفی و کنترل شده با گروه های موازی یک سویه کور، فاز 3 بر روی 36 بیمار. شرکت کنندگان به کمک نرم افزار و با روش تصادفی سازی block Randomization در3 گروه درمان با سوزن خشک، گروه سوزن خشک پلاسبو و گروه بدون درمان قرار می گیرند.
    -کارآزمایی بالینی تصادفی و کنترل شده با گروه های موازی یک سویه کور، بر روی 36 بیمار. تصادفی سازی با استفاده از یک سرویس تصادفی مرکزی کامپیوتری مبتنی بر اینترنت (www.sealedenvelope.com) انجام خواهد شد. تخصیص و مخفی سازی تخصیص در پاکت های غیر شفاف با شماره متوالی توسط شخصی که هیچ نقش مستقیمی در مطالعه نداشته است مهر و موم می شود. زنان به طور تصادفی در گروه سوزن خشک (DNG)، گروه دارونما (PNG) و گروه کنترل (CG) قرار خواهند گرفت.
    Females will be randomly assigned to dry needling, placebo-needling, and no treatment group
    dry needling group (DNG), placebo needling group (PNG), control group (CG)
    زنان به‌طور تصادفی در گروه‌های درای نیدلینگ، پلاسبو-نیدلینگ و بدون درمان قرار می‌گیرند
    زنان به‌طور تصادفی در گروه‌های سوزن خشک (DNG)، گروه سوزن پلاسبو (PNG) و گروه کنترل (CG) قرار می‌گیرند
    Pain -overall score of the Central sensitization Inventory (CSI) EEG activity of the brain -conditional pain modulation -saliva cortisol biomarker
    -short-form McGill pain questionnaire -Central Sensitization Inventory -electroencephalography -conditional pain modulation -salivary cortisol concentration
    -درد -نمره کلی پرسشنامه حساسیت مرکزی (CSI) -فعالیت EEG مغز -تعدیل درد شرطی -بیومارکر کورتیزول بزاق
    - پرسشنامه درد مک گیل فرم کوتاه (SF-MPQ) - پرسشنامه حساسیت مرکزی (CSI) -الکتروآنسفالوگرافی (EEG) - مدولاسیون درد شرطی (CPM) - غلظت کورتیزول بزاق
  • General information

    empty
    35
    empty
    2021-12-22, 1400/10/01
    empty
    2023-01-20, 1401/10/30
    empty
    2023-01-20, 1401/10/30
    empty
    Adding secondary variables to the summary and adding abbreviations to the text and minor changes to the intervention (placebo method)
    empty
    افزودن متغیرهای ثانویه به خلاصه و افزودن مخفف ها به متن و تغییر جزیی مداخله (روش پلاسبو)
  • Primary outcomes

    #1
    EEG (recording frequency bands of Delta (1.0-4.0 Hz), Theta (4.0-8.0 Hz), Alpha (8.0-12.0 Hz) and Beta (12.0-25.0 Hz))
    Electroencephalography (EEG) (recording power of frequency bands of Delta (1.0-4.0 Hz), Theta (4.0-8.0 Hz), Alpha (8.0-12.0 Hz) and Beta (12.0-25.0 Hz))
    EEG (ثبت باندهای فرکانسی دلتا (1.0-4.0 هرتز) ، تتا (4.0-8.0 هرتز) ، آلفا (8.0-12.0 هرتز) و بتا (12.0-25.0 هرتز))
    الکتروانسفالوگرافی (ثبت توان باندهای فرکانسی دلتا (1.0-4.0 هرتز) ، تتا (4.0-8.0 هرتز) ، آلفا (8.0-12.0 هرتز) و بتا (12.0-25.0 هرتز))
    #2
    Measurement of salivary cortisol levels
    Measurement of salivary cortisol concentration
    اندازه گیری سطح کورتیزول بزاق
    اندازه گیری غلظت کورتیزول بزاقی
  • Intervention groups

    #1
    Intervention group: Dry needling group: DN sessions begin immediately 1 day after the baseline assessment (days 7 to 11 of the menstrual cycle) until before the next menstrual period in women. During this period (from the baseline assessment until the start of the next menstrual cycle), patients will receive 5 sessions of DN with an interval of at least 48 and a maximum of 72 hours. Patients will receive a DN using disposable stainless steel needles (0.25 mm × 50 mm) brand (Korean Dong Bang) that will be inserted through the skin into a taut band of trigger points. Treatment steps include hand washing, Wearing disposable examination gloves, and cleansing participants' skin with an alcohol swab before treatment. Deep Needle Drying of the abdominal, gluteal, and pelvic floor muscles will be performed according to Dommerholt Second Edition (146). Since repeated and severe manipulation of the needle may cause excessive damage and increase inflammatory pain in skeletal muscle fibers (129), so the method of "static needling" will be used so that when the needle penetrates the skin and Entered the muscle, the needle will be left in the muscle (189). For "moderate respondents" Baldry recommends placing the needle in place for 30-60 seconds or in "weak respondents" for 2-3 minutes. It will be compressed for 5-10 seconds, or 30 minutes for -60 if there is bleeding. This helps to ensure adequate homeostasis. Muscles that receive dry needles include the rectus abdominis, internal and external oblique muscles, gluteus maximus, gluteus muscle. The medius will be the gluteus minimus muscle, the obturator intrnus muscle, the piriformis muscle, the pubococcygeus, the iliococcygeus, and the coccygeus.
    Intervention group: Dry needling group (DNG): Females in DNG will receive 5 sessions of DN with an interval of at least 48 and at most 72 hours. The DN sessions will be scheduled immediately 1 day after baseline assessment (days 7-11 of the menstrual cycle). DN will be performed according to the second edition of Dommerholt (2018) [48], into active and latent MTrPs of the mentioned muscles. Females will receive DN using disposable stainless 0.25mm×50 mm needles (Bang Dong brand (Korean). Considering that frequent and severe manipulation of the needle may cause excessive damage and increase inflammatory pain in skeletal muscle fibers [51], the "static needling" method will be used in such a way that when the needle penetrates the skin and enters the muscle, the needle will be left in the muscle for seconds without manipulation [52]. Each needle will be kept in the muscle for up to 2 minutes according to Bradly’s category of patients to either strong, average, or weak responders to acupuncture [53]. After removing the needle, the tissue is compressed using a cotton swab for 10-5 seconds, or 30-60 seconds if bleeding is present [48]. Muscles that receive dry needles include the rectus abdominis, internal and external oblique muscles, gluteus maximus, medius, and minimus muscles, the obturator intrnus muscle, the piriformis muscle, the pubococcygeus, the iliococcygeus, and the coccygeus.
    گروه مداخله: سوزن خشک: جلسه های DNبلافاصله 1روز پس از ارزیابی اولیه (روزهای 7تا 11چرخه قاعدگی) تا قبل از شروع دوره قاعدگی بعدی زنان شروع می شود. در این بازه زمانی (از زمان ارزیابی تا شروع چرخه قاعدگی بعدی) بیماران 5جلسه درمانی با سوزن خشک با فاصله حداقل 48و حداکثر 72ساعت دریافت خواهند کرد. بیماران سوزن خشک را بااستفاده از سوزن های ضد زنگ یکبار مصرف ( 0,25میلی متر × 50میلی متر ، مارک ( Dong Bangکره ای) که از طریق پوست وارد باند سفت نقاط ماشه ای خواهد شد دریافت خواهند کرد. مراحل درمان شامل شستن دست ها ، پوشیدن دستکش معاینه یکبار مصرف و تمیز کردن پوست شرکت کنندگان با سواب الکل قبل از درمان خواهدبود. روش سوزن خشک عمقی 1عضلات دیواره شکم، گلوتئال و کف لگن بر طبق Dommerholtچاپ دوم( )146انجام خواهد شد. با توجه به اینکه دستکاری مکرر و شدید سوزن ممکن است باعث آسیب بیش از حد وافزایش درد التهابی در فیبر های عضلانی اسکلتی شود( ،)129لذا از روش "سوزن زدن استاتیک "استفاده خواهدشد به این صورت که هنگامی که سوزن به پوست نفوذ کرد و به عضله وارد شد ، سوزن در عضله باقی گذاشته خواهد شد( Baldry .)189توصیه می کند برای "پاسخ دهندگان متوسط "سوزن به مدت 60-30ثانیه در محل گذاشته شود و یا در "پاسخ دهندگان ضعیف "تا 3-2دقیقه در محل گذاشته شود.پس از خارج کردن سوزن ، بافت با استفاده از سواب پنبه برای 10-5ثانیه، یا در صورت وجود خونریزی برای -60 30ثانیه فشرده خواهد شد این به اطمینان از هموستاز کافی کمک می کند.عضلاتی که سوزن خشک را دریافت میکنند شامل عضله راست شکمی، عضلات مورب داخلی و خارجی، عضله گلوتئوس ماگزیموس، عضله گلوتئوس مدیوس، عضله گلوتئوس مینیموس، عضله اوبتوراتور داخلی، عضله پیریفورمیس، پوبوکوکسیژئوس، ایلیوکوکسیژئوس و کوکسیژئوس خواهد بود.
    گروه مداخله: گروه سوزن خشک (DNG): زنان در DNG 5 جلسه DN با فاصله حداقل 48 و حداکثر 72 ساعت دریافت خواهند کرد. جلسات DN بلافاصله 1 روز پس از ارزیابی پایه (روزهای 7-11 سیکل قاعدگی) برنامه ریزی می شود. DN مطابق ویرایش دوم Dommerholt (2018) [48] در MTrPهای فعال و نهفته عضلات ذکر شده انجام خواهد شد. خانم‌ها DN را با استفاده از سوزن‌های 0.25 میلی‌متر در 50 میلی‌متر ضد زنگ یکبار مصرف (با نام تجاری Bang Dong (کره‌ای) دریافت می‌کنند. با توجه به اینکه دستکاری مکرر و شدید سوزن ممکن است باعث آسیب بیش از حد و افزایش درد التهابی در فیبرهای عضلانی اسکلتی شود [51]، سوزن‌زنی استاتیک این روش به این صورت است که وقتی سوزن به پوست نفوذ می کند و وارد عضله می شود، سوزن برای چند ثانیه بدون دستکاری در عضله باقی می ماند [52]. هر سوزن تا 2 دقیقه در عضله باقی می ماند. با توجه به دسته بندی برادلی از بیماران برای پاسخ دهندگان قوی، متوسط یا ضعیف به طب سوزنی [53]. پس از برداشتن سوزن، بافت با استفاده از یک سواب پنبه ای به مدت 10-5 ثانیه یا 30-60 ثانیه در صورت وجود خونریزی فشرده می شود. 48].عضلاتی که سوزن خشک را دریافت میکنند شامل عضله راست شکمی، عضلات مورب داخلی و خارجی، عضله گلوتئوس ماگزیموس، عضله گلوتئوس مدیوس، عضله گلوتئوس مینیموس، عضله اوبتوراتور داخلی، عضله پیریفورمیس، پوبوکوکسیژئوس، ایلیوکوکسیژئوس و کوکسیژئوس خواهد بود.
    #2
    Intervention group: Placebo dry needling group: The women in this group receive the same needling method as the DN group but with a non-penetrating "Dong Bang" needle. These needles look like penetrating needles. The therapist will perform the same procedure as with a real needle in the DN group to guide people. These placebo needles provide mechanical stimulus to the tissue without puncturing the skin. Patients experience a feeling of pressure very similar to a real needle.
    Intervention group: Placebo needling group (PNG): Females assigned to the PNG will receive a placebo needle procedure, the same as the DNG but using a non-penetrating method. The physiotherapist will perform the same procedure as with a real needle in the DNG to blind the patients. The needle guide will be only put over the skin, creating a mechanical stimulus on the tissue without making a hole. Patients experience a pressure sensation very similar to a real needle [54]. In PNG, each needle will be kept over the skin for 30 seconds.
    گروه مداخله: گروه سوزن خشک پلاسبو: زنان در این گروه ، همان روش needlingمشابه گروه DNاما با استفاده از سوزن غیر نفوذی " Dong" Bangرا دریافت می کنند. این سوزن ها بسیار شبیه به سوزن های نفوذکننده به نظر می رسند. درمانگر همان روش را که با یک سوزن واقعی در گروه DNانجام میشود ، انجام خواهد داد تاشرکت کنندگان را کورسو کند. این سوزنهای دارونما بدون ایجاد سوراخ در پوست ، محرک مکانیکی بر روی بافت ایجاد می کنند. بیماران احساس فشار بسیار مشابه با یک سوزن طبیعی را تجربه میکنند.
    گروه مداخله: گروه سوزن پلاسبو (PNG): زنانی که به PNG اختصاص داده شده اند، یک روش سوزن پلاسبو، مشابه DNG، اما با استفاده از یک روش غیر نفوذی، دریافت خواهند کرد. فیزیوتراپیست همان روشی را که با یک سوزن واقعی در DNG انجام می دهد تا بیماران را کور کند. راهنمای سوزن فقط روی پوست گذاشته می شود و بدون ایجاد سوراخ، یک محرک مکانیکی روی بافت ایجاد می کند. بیماران یک احساس فشار بسیار شبیه به یک سوزن واقعی را تجربه می کنند [54]. در PNG، هر سوزن به مدت 30 ثانیه روی پوست نگه داشته می شود.
    #3
    Control group: untreated group: Women assigned to the untreated group will not receive any needle intervention and just will be evaluatedat specified intervals.
    Control group (CG) (No- treatment) Women assigned to the CG received no needle intervention.
    گروه کنترل: گروه بدون درمان: زنانی که به گروه بدون درمان اختصاص داده میشوند هیچ مداخله سوزنی دریافت نمیکنند و تنها در بازه های زمانی مشخص شده ارزیابی میشوند.
    گروه کنترل (CG) (گروه بدون درمان): زنانی که به گروه بدون درمان اختصاص داده میشوند هیچ مداخله سوزنی دریافت نمیکنند و تنها در بازه های زمانی مشخص شده ارزیابی میشوند.
  • Recruitment centers

    #1
    Name of recruitment center - English: gynecology clinics of hospitals affiliated to the shiraz university of medical sciences
    Name of recruitment center - Persian: درمانگاه های زنان وابسته به دانشگاه علوم پزشکی شیراز
    Full name of responsible person - English: Dr. Mehrzad Lotfi
    Full name of responsible person - Persian: دکتر مهرزاد لطفی
    Street address - English: Headquarters of Shiraz University of Medical Sciences, Zand Street
    Street address - Persian: شیراز، خیابان کریم خان زند، روبروی خیابان فلسطین، ساختمان مرکزی دانشگاه علوم پزشکی و خدمات بهداشتی درمانی شیراز
    City - English: Shiraz
    City - Persian: شیراز
    Province: Fars
    Country: Iran (Islamic Republic of)
    Postal code: ۱۴۳۳۶ - ۷۱۳۴۸
    Phone: +98 71 3230 5410
    Fax:
    Email: riasat@sums.ac.ir
    Web page address:
    Name of recruitment center - English: gynecology clinics of hospitals affiliated to the shiraz university of medical sciences
    Name of recruitment center - Persian: درمانگاه های زنان وابسته به دانشگاه علوم پزشکی شیراز
    Full name of responsible person - English: Dr. Mehrzad Lotfi
    Full name of responsible person - Persian: دکتر مهرزاد لطفی
    Street address - English: Headquarters of Shiraz University of Medical Sciences, Zand Street
    Street address - Persian: شیراز، خیابان کریم خان زند، روبروی خیابان فلسطین، ساختمان مرکزی دانشگاه علوم پزشکی و خدمات بهداشتی درمانی شیراز
    City - English: Shiraz
    City - Persian: شیراز
    Province: Fars
    Country: Iran (Islamic Republic of)
    Postal code: 71348-14336
    Phone: +98 71 3230 5410
    Fax:
    Email: riasat@sums.ac.ir
    Web page address:
  • Sponsors / Funding sources

    #1

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Dr. Mehrzad Lotfi
    Full name of responsible person - Persian: دکتر مهرزاد لطفی
    Street address - English: Headquarters of Shiraz University of Medical Sciences, Zand Street, Shiraz
    Street address - Persian: شیراز، خیابان زند، روبروی خیابان فلسطین، ساختمان مرکزی دانشگاه علوم پزشکی شیراز
    City - English: Shiraz
    City - Persian: شیراز
    Province: Fars
    Country: Iran (Islamic Republic of)
    Postal code: ۱۴۳۳۶ - ۷۱۳۴۸
    Phone: +98 71 3230 5410
    Fax:
    Email: riasat@sums.ac.ir
    Web page address:

    Name of organization / entity - English:
    Name of organization / entity - Persian:
    Full name of responsible person - English: Dr. Mehrzad Lotfi
    Full name of responsible person - Persian: دکتر مهرزاد لطفی
    Street address - English: Headquarters of Shiraz University of Medical Sciences, Zand Street, Shiraz
    Street address - Persian: شیراز، خیابان زند، روبروی خیابان فلسطین، ساختمان مرکزی دانشگاه علوم پزشکی شیراز
    City - English: Shiraz
    City - Persian: شیراز
    Province: Fars
    Country: Iran (Islamic Republic of)
    Postal code: 71348-14336
    Phone: +98 71 3230 5410
    Fax:
    Email: riasat@sums.ac.ir
    Web page address:

Protocol summary

Study aim
The effect of dry needling on pain and central sensitization (including the Central Sensitization Inventory, electroencephalography, conditional pain modulation, salivary cortisol concentration, and psychosocial variables (7-item general anxiety disorder scale, pain catastrophizing scale, and SF-36 questionnaire) in women with chronic pelvic pain.
Design
Single-blind randomized, parallel-group controlled clinical trial, on 36 patients. Randomization will be performed using a computerized Internet-based central randomization service (www.sealedenvelope.com). Assignments and allocation concealment will be sealed in sequentially numbered opaque envelopes by a person who had no direct role in the study.
Settings and conduct
Women will be recruited based on the definition of CPP and recognition by an expert in female pelvic floor physicians. All assessments and interventions will conduct in the Research Center of the Faculty of Rehabilitation Sciences of Shiraz University of Medical Sciences.
Participants/Inclusion and exclusion criteria
1. Non-pregnant women in an age range of 20-50 years who are not menopausal, and feel recurrent or constant pain in the pelvis, perineum, anterior abdominal wall below the umbilicus, or in the lower back, pelvic pain unrelated to menstruation, intercourse, or pregnancy lasting for at least 6months. 2. Presence of tenderness/pain when touched in at least one pelvic floor muscle including the levator ani , obturator internus, piriformis, rectus abdominis and external obliqus muscles, and gluteal muscles 3. Score 40-59 in CSI questionnaire (moderate to severe central sensitization level)
Intervention groups
dry needling group (DNG), placebo needling group (PNG), control group (CG)
Main outcome variables
-short-form McGill pain questionnaire -Central Sensitization Inventory -electroencephalography -conditional pain modulation -salivary cortisol concentration

General information

Reason for update
Adding secondary variables to the summary and adding abbreviations to the text and minor changes to the intervention (placebo method)
Acronym
IRCT registration information
IRCT registration number: IRCT20211114053057N1
Registration date: 2021-12-03, 1400/09/12
Registration timing: prospective

Last update: 2024-03-25, 1403/01/06
Update count: 1
Registration date
2021-12-03, 1400/09/12
Registrant information
Name
Najmeh Sedighimehr
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 71 3627 1551
Email address
najmehsedighimehr@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2021-12-06, 1400/09/15
Expected recruitment end date
2022-08-22, 1401/05/31
Actual recruitment start date
2021-12-22, 1400/10/01
Actual recruitment end date
2023-01-20, 1401/10/30
Trial completion date
2023-01-20, 1401/10/30
Scientific title
The effect of dry needling on pain and central sensitization in women with chronic pelvic pain: a randomized parallel-group controlled clinical trial
Public title
The effect of dry needling on pain and central sensitization in women with chronic pelvic pain
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
1.non-pregnant women in an age range of 20e50 years who are not menopausal, and feel recurrent or constant pain in the pelvis, perineum, anterior abdominal wall below the umbilicus, or in the lower back, pelvic pain unrelated to menstruation, intercourse, or pregnancy lasting for at least 6months. 2. Presence of tenderness / pain when touched by a physician at visit 1 and physiotherapist at visit 2 in at least one pelvic floor muscle including the levator ani ( pubococcygeus, iliococcygeus and coccygeus), obturator internus, piriformis, rectus abdominis and external obliqus muscles, and gluteal muscles including gluteus maximus, medius, and minimus . Muscles will be evaluated bilaterally. The presence of MTrP will be confirmed according to Travel and Simons diagnostic criteria, which are as follows: palpation of a taut band; , identification of an exquisitely tender nodule (MTrP) in the taut band; and reproduction of the patient's symptomatic pain with sustained pressure. tenderness/ pain assessments at visits 1 and 2 do not have to be the same in severity or location for the participant to be eligible. 3. Score 40-59 in CSI questionnaire (moderate to severe central sensitization level)
Exclusion criteria:
1. Active pelvic inflammatory disease, cancer, chronic pain in other areas (knee, neck, back, temporomandibular joint, and fibromyalgia syndrome), specific low back pain (proven low back pain due to disc herniation, stenosis, and spondylolisthesis), non-specific low back pain in last three months leading to treatment intervention and rest (145). 2. Taking physical therapy interventions in the last three months for pelvic pain (94, 95). 3. Contraindications and precautions related to dry needling: -Absolute contraindications:1. In a patient with needle phobia.2. Patient unwilling – fear, patient belief.3. Unable to give consent – communication, cognitive, age-related factors.4. Medical emergency or acute medical condition.5. Over an area or limb with lymphedema as this may increase the risk of infection/cellulitis and the difficulty of fighting the infection if one should occur .6. Inappropriate for any other reason.- Relative contraindications: 1. Abnormal bleeding tendency (e.g. hemophilia, blood thinning medication, etc.).2. Compromised immune system (1. Disease-related immunocompromised patients(e.g. blood-borne diseases, cancer, HIV, hepatitis, endocarditis, incompetent heart valve or valve replacements, etc.).2. Immunocompromised patients from immunosuppression therapy (e.g. drug cancer therapy).3. Acute immune disorders (e.g. acute states of rheumatoid arthritis, current infection – local or systemic, etc.).4. Debilitated patients and those with chronic illness, among others.). 3. Diabetes. 4. Patients with epilepsy, or Psychological status. Contraindications and precautions related to CPM and ice bath: Peripheral vascular defects or injuries - Cold sensitivity (vasospasm, cryoglobulinemia, cold urticaria) - Heart disease - Hypertension - Sensory defects - Emotional and psychological characteristics (147). Contraindications and precautions related to EEG recording: Diagnosed psychiatric disorders including dissociative disorder, obsessive-compulsive disorder, personality disorder, schizophrenia, and bipolar disorder - history of drug and alcohol dependence or substance abuse disorders - history of seizures - head trauma with loss of consciousness (64).
Age
From 20 years old to 50 years old
Gender
Female
Phase
N/A
Groups that have been masked
  • Outcome assessor
Sample size
Target sample size: 36
Actual sample size reached: 35
Randomization (investigator's opinion)
Randomized
Randomization description
Participants will be divided into 3 groups of dry needling, placebo, and untreated control group with block randomization method using a randomization software.
Blinding (investigator's opinion)
Single blinded
Blinding description
The assessor will be blind to group assignments.
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Research Ethics Committees of Shiraz School of Rehabilitation Sciences
Street address
Shiraz School of Rehabilitation Sciences, Abiverdi 1 Ave., Chamran Blvd.
City
Shiraz
Province
Fars
Postal code
14336 - 71348
Approval date
2021-11-03, 1400/08/12
Ethics committee reference number
IR.SUMS.REHAB.REC.1400.035

Health conditions studied

1

Description of health condition studied
chronic pelvic pain
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Pain intensity
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
short form of McGill Pain Questionnaire (SF-MPQ)

2

Description
Central Sensitization
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
Central Sensitization Inventory (CSI)

3

Description
Functional changes in the brain as an indicator of central sensitization
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
Electroencephalography (EEG) (recording power of frequency bands of Delta (1.0-4.0 Hz), Theta (4.0-8.0 Hz), Alpha (8.0-12.0 Hz) and Beta (12.0-25.0 Hz))

4

Description
Changes in endogenous central pain inhibitory system as an indicator of central sensitization
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
Conditioned pain modulation

5

Description
Changes in Hypothalamic-pituitary-adrenal (HPA) Axis as an indicator of central sensitization
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
Measurement of salivary cortisol concentration

Secondary outcomes

1

Description
Health related Quality of Life
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
Short Form Health Survey (SF-36)

2

Description
Pain Catastrophizing
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
Pain Catastrophizing Scale(PCS)

3

Description
Anxiety level
Timepoint
At baseline (before the intervention), after the end of the intervention and 3 months after the intervention
Method of measurement
7-items General Anxiety Disorder scale (GAD-7)

Intervention groups

1

Description
Intervention group: Dry needling group (DNG): Females in DNG will receive 5 sessions of DN with an interval of at least 48 and at most 72 hours. The DN sessions will be scheduled immediately 1 day after baseline assessment (days 7-11 of the menstrual cycle). DN will be performed according to the second edition of Dommerholt (2018) [48], into active and latent MTrPs of the mentioned muscles. Females will receive DN using disposable stainless 0.25mm×50 mm needles (Bang Dong brand (Korean). Considering that frequent and severe manipulation of the needle may cause excessive damage and increase inflammatory pain in skeletal muscle fibers [51], the "static needling" method will be used in such a way that when the needle penetrates the skin and enters the muscle, the needle will be left in the muscle for seconds without manipulation [52]. Each needle will be kept in the muscle for up to 2 minutes according to Bradly’s category of patients to either strong, average, or weak responders to acupuncture [53]. After removing the needle, the tissue is compressed using a cotton swab for 10-5 seconds, or 30-60 seconds if bleeding is present [48]. Muscles that receive dry needles include the rectus abdominis, internal and external oblique muscles, gluteus maximus, medius, and minimus muscles, the obturator intrnus muscle, the piriformis muscle, the pubococcygeus, the iliococcygeus, and the coccygeus.
Category
Treatment - Other

2

Description
Intervention group: Placebo needling group (PNG): Females assigned to the PNG will receive a placebo needle procedure, the same as the DNG but using a non-penetrating method. The physiotherapist will perform the same procedure as with a real needle in the DNG to blind the patients. The needle guide will be only put over the skin, creating a mechanical stimulus on the tissue without making a hole. Patients experience a pressure sensation very similar to a real needle [54]. In PNG, each needle will be kept over the skin for 30 seconds.
Category
Placebo

3

Description
Control group (CG) (No- treatment) Women assigned to the CG received no needle intervention.
Category
Other

Recruitment centers

1

Recruitment center
Name of recruitment center
gynecology clinics of hospitals affiliated to the shiraz university of medical sciences
Full name of responsible person
Dr. Mehrzad Lotfi
Street address
Headquarters of Shiraz University of Medical Sciences, Zand Street
City
Shiraz
Province
Fars
Postal code
71348-14336
Phone
+98 71 3230 5410
Email
riasat@sums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Dr. Mehrzad Lotfi
Street address
Headquarters of Shiraz University of Medical Sciences, Zand Street, Shiraz
City
Shiraz
Province
Fars
Postal code
71348-14336
Phone
+98 71 3230 5410
Email
riasat@sums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Shiraz University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Najmeh Sedighimehr
Position
PhD candidate
Latest degree
Ph.D.
Other areas of specialty/work
Physiotherapy
Street address
Faculty of Shiraz Rehabilitation Sciences, Abiverdi 1 Ave., Chamran Blvd., Shiraz
City
Shiraz
Province
Fars
Postal code
33669-71947
Phone
+98 71 3627 1551
Email
najmehsedighimehr@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Najmeh Sedighimehr
Position
PhD candidate
Latest degree
Ph.D.
Other areas of specialty/work
Physiotherapy
Street address
School of Rehabilitation Sciences, Abiverdi 1 Ave, Chamran Blvd, Shiraz, Iran
City
Shiraz
Province
Fars
Postal code
33669-71947
Phone
+98 71 3627 1551
Fax
Email
najmehsedighimehr@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Shiraz University of Medical Sciences
Full name of responsible person
Najmeh Sedighimehr
Position
PhD candidate
Latest degree
Ph.D.
Other areas of specialty/work
Physiotherapy
Street address
School of Rehabilitation Sciences, Abiverdi 1 Ave, Chamran Blvd, Shiraz, Iran
City
Shiraz
Province
Fars
Postal code
33669-71947
Phone
+98 71 3627 1551
Fax
Email
najmehsedighimehr@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Yes - There is a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
The study protocol, statistical analysis map, and clinical study report will be published in full after the end of the study and in the form of a published article. Participant data file (IPD) and informed consent form will be published after the end of the study and at the request of the journal, in the form of supplementary data in the published article. The codes used in the analysis and data classification system (data dictionary) will be provided to the corresponding author of the article after the end of the study and will be provided to the journal, university center, or academics upon request.
When the data will become available and for how long
After the end of the study and publication of the article
To whom data/document is available
All applicants
Under which criteria data/document could be used
For scientific and research purposes and after the publication of the article
From where data/document is obtainable
The corresponding author of the article that will be published. His/Her contact information including email, contact number, and university address will be available in the article.
What processes are involved for a request to access data/document
The applicant must send his / her request for data/documentation by e-mail to the corresponding author of the article.
Comments
Loading...